Tag: Steve Jobs carcinoid

A Possible Cure for Neuroendocrine Cancer: Exciting Update!

Back in September 2012 we shared the following:  “For $1.6 million (1 million pounds) an oncolytic virus that has the potential to cure neuroendocrine cancer can be named for the donor.  At Uppsala University in Sweden researchers are ready to start a …

10 Highlights of the Year 2011 for the Carcinoid and Neuroendocrine Tumor Community

As the Carcinoid Cancer Foundation looks back on the year 2011, there were many significant events and advances for the carcinoid and neuroendocrine tumor (NET) community.  Here are 10 of the year’s important stories:

1)     The FDA approved the first…

Breaking News: Steve Jobs, Co-Founder and Former CEO of Apple, Has Died

The Carcinoid Cancer Foundation and the carcinoid/NET community express their deepest sympathies to the family, friends and colleagues of Steve Jobs, former CEO of Apple, who died on Wednesday, October 5, 2011.  Mr. Jobs was diagnosed with an islet …

Pancreatic Neuroendocrine Tumors: A Rare Cancer

From your next door neighbor to Steve Jobs, co-founder of Apple who just announced that he is stepping down as CEO of the company, pancreatic neuroendocrine tumors (pNETs) affect less than 1 person in 100,000 in the United States.  This rare cancer is often…

Breaking News: FDA Approves Pfizer’s Sutent for Pancreatic NET Cancer Patients

The US Food and Drug Administration today announced approval of Pfizer’s Sutent (sunitinib) for advanced pancreatic neuroendocrine tumor cancer patients with tumors that cannot be removed by surgery or that have spread  (metastasized) to …

Breaking News: FDA Approves Pfizer’s Sutent for Pancreatic NET Cancer Patients

The US Food and Drug Administration today announced approval of Pfizer’s Sutent (sunitinib) for advanced pancreatic neuroendocrine tumor cancer patients with tumors that cannot be removed by surgery or that have spread  (metastasized) to …

Carcinoid Cancer Foundation Thanks Steve Jobs for Bringing about Greater Awareness of Neuroendocrine Cancers

Since the announcement was made earlier this month that Apple’s CEO Steve Jobs would be taking a medical leave of absence there has been significant media coverage about pancreatic neuroendocrine tumors, NET cancer, and carcinoid.  Although…

Fortune Reports That Steve Jobs Sought Neuroendocrine Cancer Treatment in Switzerland

Fortune reported today, January 18, 2011, that Apple’s CEO Steve Jobs went to Basel, Switzerland in 2009 seeking treatment for neuroendocrine cancer. Read the story HERE.…